We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WOW
951
DELISTED
WideOpenWest
WOW
| $530K | ﹤0.01% |
+74,087
| New | +$713K |
|
952
Northeast Bank
NBN
$1.14B
| $523K | ﹤0.01% |
25,526
-3,610
| -12% | -$81.2K |
|
953
MGIC Investment
MTG
$6.19B
| $519K | ﹤0.01% |
39,900
-5,500
| -12% | -$77.9K |
|
|
SDLP
954
DELISTED
SEADRILL PARTNERS LLC
SDLP
| $515K | ﹤0.01% |
18,729
-36,236
| -66% | -$1.23M |
|
955
New Mountain Finance
NMFC
$725M
| $512K | ﹤0.01% |
38,938
-226,278
| -85% | -$2.99M |
|
|
CMO
956
DELISTED
Capstead Mortgage Corp.
CMO
| $505K | ﹤0.01% |
+58,400
| New | +$506K |
|
|
SXCP
957
DELISTED
SunCoke Energy Partners, L.P.
SXCP
| $501K | ﹤0.01% |
28,172
-92,358
| -77% | -$1.76M |
|
958
Akebia Therapeutics
AKBA
$234M
| $500K | ﹤0.01% |
+52,500
| New | +$734K |
|
959
Micron Technology
MU
$995B
| $490K | ﹤0.01% |
9,400
-4,747,237
| -100% | -$227M |
|
960
VICI Properties
VICI
$28.7B
| $484K | ﹤0.01% |
+26,400
| New | +$517K |
|
|
VRE
961
DELISTED
Veris Residential
VRE
| $483K | ﹤0.01% |
+28,900
| New | +$546K |
|
|
CCXI
962
DELISTED
ChemoCentryx, Inc.
CCXI
| $465K | ﹤0.01% |
34,216
+8,200
| +32% | +$84.6K |
|
|
TWTR
963
DELISTED
Twitter, Inc.
TWTR
| $464K | ﹤0.01% |
+15,997
| New | +$469K |
|
964
Ducommun
DCO
$3B
| $462K | ﹤0.01% |
15,215
-18,207
| -54% | -$526K |
|
|
TERP
965
DELISTED
TerraForm Power, Inc
TERP
| $460K | ﹤0.01% |
+42,900
| New | +$483K |
|
966
Bio-Techne
TECH
$11.2B
| $453K | ﹤0.01% |
+12,000
| New | +$424K |
|
|
TEN
967
Tsakos Energy Navigation Ltd
TEN
$1.17B
| $452K | ﹤0.01% |
27,391
+8,269
| +43% | +$149K |
|
968
Farmers National Banc Corp
FMNB
$928M
| $445K | ﹤0.01% |
32,146
-2,700
| -8% | -$39.3K |
|
|
EGRX
969
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $440K | ﹤0.01% |
8,348
-167,838
| -95% | -$9.76M |
|
970
Amtech Systems
ASYS
$265M
| $439K | ﹤0.01% |
59,972
+6,025
| +11% | +$54.2K |
|
|
ARNA
971
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $437K | ﹤0.01% |
+11,057
| New | +$430K |
|
|
AAV
972
DELISTED
Advantage Oil & Gas Ltd
AAV
| $436K | ﹤0.01% |
147,965
-267,435
| -64% | -$865K |
|
|
JCP
973
DELISTED
J.C. Penney Company, Inc.
JCP
| $432K | ﹤0.01% |
+143,150
| New | +$516K |
|
|
MVC
974
DELISTED
MVC Capital, Inc.
MVC
| $431K | ﹤0.01% |
43,416
-2,684
| -6% | -$27.8K |
|
975
Humana
HUM
$46.5B
| $430K | ﹤0.01% |
1,600
-149,572
| -99% | -$40.5M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.